US Patent Issued to Dr. Falk Pharma on June 23 for "Systemic formulation of a pyridinone derivate for coeliac disease" (German Inventors)

ALEXANDRIA, Va., July 15 -- United States Patent no. 12,661,347, issued on June 23, was assigned to Dr. Falk Pharma GmbH (Freiburg, Germany).

"Systemic formulation of a pyridinone derivate for coeliac disease" was invented by Roland Greinwald (Kenzingen, Germany), Wolfgang Mohr (Freiburg, Germany), Bernhard Tewes (Vorstetten, Germany), Rudolf Wilhelm (Bischweier, Germany) and Ralf Mohrbacher (Freiburg, Germany).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention relates to a systemic formulation, in particular an oral formulation, for the prophylaxis and/or treatment of coeliac disease, i.e. for use in the prophylaxis and/or treatment of coeliac disease."

The patent was filed on April 24, 20...